Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Non-Current Assets (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Other Non-Current Assets data on record, last reported at $459000.0 in Q3 2023.

  • For Q3 2023, Other Non-Current Assets changed 0.22% year-over-year to $459000.0; the TTM value through Sep 2023 reached $459000.0, changed 0.22%, while the annual FY2022 figure was $459000.0, 212.24% up from the prior year.
  • Other Non-Current Assets reached $459000.0 in Q3 2023 per CGEM's latest filing, roughly flat from $459000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.3 million in Q4 2020 and bottomed at $100000.0 in Q2 2022.
  • Average Other Non-Current Assets over 4 years is $452583.3, with a median of $303000.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: tumbled 93.61% in 2021, then skyrocketed 359.0% in 2023.
  • A 4-year view of Other Non-Current Assets shows it stood at $2.3 million in 2020, then crashed by 93.61% to $147000.0 in 2021, then soared by 212.24% to $459000.0 in 2022, then changed by 0.0% to $459000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $459000.0 in Q3 2023, $459000.0 in Q2 2023, and $459000.0 in Q1 2023.